Design
Review
Authors
Loading...
May enable smaller placebo-free antihypertensive trials; leaves open protocol standardization amid technical constraints.
ABPM offers significant methodological advantages for antihypertensive drug trials, potentially reducing required sample sizes and eliminating the need for placebo groups, despite some current technical limitations.
Mancia et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: